Calumet, Inc. (CLMT)

Blueprint Medicines Revenue

Calumet had revenue of $993.90M in the quarter ending March 31, 2025, a decrease of -1.18%. This brings the company's revenue in the last twelve months to $4.18B, up 0.67% year-over-year. In the year 2024, Calumet had annual revenue of $4.19B with 0.20% growth.

• Revenue (ttm): $4.18B
• Revenue Growth: +0.67%
• P/S Ratio: 0.31
• Revenue / Employee: $2,578,704
• Employees: 1,620
• Market Cap: 1.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.19B	8.40M	0.20%
Dec 31, 2023	4.18B	-505.30M	-10.78%
Dec 31, 2022	4.69B	1.54B	48.87%
Dec 31, 2021	3.15B	879.80M	38.79%
Dec 31, 2020	2.27B	-1.18B	-34.30%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.